Last reviewed · How we verify
NCT04723407: RICOVID19
Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism
trial testing questionnaires in Rheumatism in 950 participants. Status unknown.
1 January 2022
Quick facts
| Lead sponsor | University Hospital, Limoges |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 950 |
| Start date | 1 February 2021 |
| Primary completion | 1 January 2022 |
| Estimated completion | 1 March 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- questionnaires
Conditions studied
- Rheumatism — all drugs for Rheumatism →
Sponsor
University Hospital, Limoges
Who can join
18 and older, any sex, with Rheumatism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with chronic inflammatory rheumatism (RIC) or autoimmune diseases, rheumatoid arthritis and spondyloarthritis, are regularly monitored in consultation as part of a "treat to target" strategy with rapid adaptation of treatments to the activity of their disease. according to French recommendations. They are treated with immunosuppressive drugs: disease-modifying treatments with very often methotrexate, associated with biotherapies or targeted therapies (JAK inhibitors) They can also be treated transiently or over the long term with corticosteroids. These treatments expose them to greater infectious risks, especially with regard to COVID19. The objective is on the one hand to assess the impact of the Covid 19 pandemic on general state of health of these patients and the evolution of their disease and on the other hand to prioritize the optimal care of these patients by including in the context of maintaining the pandemic reduction rules, modern telemedicine technologies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04723407
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of questionnaires
Trials testing the same drug.
- NCT07533968 — The Aim of This Study is to Gain Insight Into the Occurrence of Irritable Bowel Symptoms During Ovarian Stimulation in I · NA · not yet recruiting
- NCT07508553 — Comparison of Bone Mineral Density in the Third Trimester Between Women in Singleton and Twin Pregnancies Using Question · NA · recruiting
- NCT05969457 — Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES App · Phase 3 · not yet recruiting
- NCT06399562 — Related Factors of Hp Infection in Physical Examination and Community Population in Hunan Province · completed
- NCT06317714 — Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs · recruiting
Other University Hospital, Limoges trials
Trials by the same sponsor.
- NCT07407101 — Impact of Filtration on Autologous Serum Eye Drops · NA · not yet recruiting
- NCT07406425 — Evaluation of Efficacy of Coconut Oil Mouth Care for Non-autonomous Hospitalised Elderly People. · NA · not yet recruiting
- NCT07436780 — B Lymphocyte Populations in the Pulmonary Microenvironment of Patients Under Mechanical Ventilation With or Without VAP · not yet recruiting
- NCT07331298 — Apparent Diffusion Coefficient of the Intervertebral Disc in Children: Pilot Study · not yet recruiting
- NCT07019818 — Esmolol Versus Sufentanil on the Quality of Post-cholecystectomy Recovery Laparoscopic Anaesthesia With Orotracheal Intu · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04723407 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Limoges
- Last refreshed: 26 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04723407.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing